Vertex Pharmaceuticals(us:VRTX)
484.74
-0.02%
Updated on 2025-04-02
Open:486.27
Close:484.74
High:491.93
Low:480.95
Prev Close:484.82
Volume:1.25M
Turnover:606.25M
Turnover Ratio:0.49%
Shares:256.79M
MarketCap:124.48B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 64 | 1001345 | 0.39% | 4 | 21 | 24 |
| 2024-03-31 | 1527 | 231608157 | 89.67% | 164 | 596 | 584 |
| 2023-12-31 | 1448 | 234827745 | 91.12% | 220 | 551 | 527 |
| 2023-09-30 | 1306 | 232232678 | 90.07% | 80 | 521 | 510 |
| 2023-06-30 | 1289 | 234003621 | 90.77% | 134 | 471 | 523 |
| 2023-03-31 | 1244 | 235198514 | 91.33% | 99 | 443 | 539 |
| 2022-12-31 | 1248 | 235584760 | 91.66% | 176 | 424 | 493 |
| 2022-09-30 | 1164 | 233523932 | 90.99% | 105 | 425 | 472 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Capital World Investors | 26707966 | 10.35% | 1140782 | 4.46% |
| 2024-06-30 | Vanguard Group Inc | 22975521 | 8.90% | 299003 | 1.32% |
| 2024-06-30 | Blackrock Inc. | 21312244 | 8.26% | -648443 | -2.95% |
| 2024-06-30 | State Street Corp | 11726076 | 4.54% | -280407 | -2.33% |
| 2024-06-30 | Fmr Llc | 10729428 | 4.16% | 55908 | 0.52% |
| 2024-06-30 | Capital Research Global Investors | 8539339 | 3.31% | 2795457 | 48.67% |
| 2024-06-30 | Alliancebernstein L.P. | 7221072 | 2.80% | 123791 | 1.74% |
| 2024-06-30 | Jpmorgan Chase & Co | 6599785 | 2.56% | 581661 | 9.66% |
| 2024-06-30 | Geode Capital Management, Llc | 6325308 | 2.45% | 512272 | 8.81% |
| 2024-06-30 | Jennison Associates Llc | 4699332 | 1.82% | -83042 | -1.74% |
About
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Address:50 Northern Avenue
Website:http://www.vrtx.com
Market Movers